4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000899243-22-030156
Chief Executive Officer sold 1,228 shares at $11.67 ($14,331)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-08-31 | Sale | −1,228 | $11.67 | $14,331 | 256,134 | D |
| Open-market sales · 1,228 sh · avg $11.67 · $14,331 | |||||||
Loading xslF345X03/doc4.xml…